ArticleHealth science reports2025
Determination of Hemagglutinin and Neuraminidase Genetic Variation of Human Influenza A(H1N1)pdm09 Virus Strain Isolated From Deceased Patients in Shiraz, Iran: A Cross-Sectional Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: A novel strain of influenza A(H1N1) was first detected in April 2009, resulting in a global pandemic. Alterations in its hemagglutinin (HA) and neuraminidase (NA) proteins can impact the virus's properties, pathogenicity, and response to treatment. Thus, ongoing epidemiological and molecular studies are crucial for effective vaccine development and management. We aimed to monitor the evolution of influenza A(H1N1) pdm09 virus (as defined by WHO) in deceased individuals during a specific period in Shiraz, Iran. Methods: A total of 200 post-mortem samples were collected from deceased individuals. Subsequently, the HA and NA gene segments of these viral isolates were subjected to targeted amplification and sequencing. Phylogenetic analysis was then conducted on the HA and NA gene sequences. Results: A total of 21 samples between 2018 and 2019 were confirmed positive for influenza A(H1N1)pdm09 viruses. All strains isolated from deceased patients belonged to subclade 6B.1, with I216T and S162N mutations. Our strains differed from the A/California/07/2009 vaccine strain, with the substitutions S203T, S185T, K163Q, and D222G observed in the HA antigenic epitope. Additionally, E224G, R223Q, and D222G mutations were detected in the RBS of HA. The NA gene analysis of influenza A(H1N1)pdm09 viruses showed sporadic detections of oseltamivir-resistance mutation, H275Y, in 5% of reported sequences. Nevertheless, no other NAI resistance-associated mutations were detected in the NA of these viruses. Conclusion: Our research strains exhibited genetic variations compared to the vaccine strains. The results of this study demonstrate the genetic diversity of influenza A(H1N1)pdm09 viruses and emphasize the critical importance of continued molecular investigations to inform effective influenza control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.